Form 4: Globus Medical SVP Kelly Huller Executes Stock Option and Sells Shares

Sentiment:

SEC Form 4 Filing


Kelly Huller, SVP, GC, and Corporate Secretary of Globus Medical, exercised stock options and sold 7,500 shares of Class A Common Stock on October 16, 2024.

Summary

  • On October 16, 2024, Kelly Huller, SVP, GC, Corporate Secretary of Globus Medical Inc., exercised stock options to acquire 7,500 shares of Class A Common Stock at a price of $25.8 per share.
  • Simultaneously, Huller sold 7,500 shares of Class A Common Stock at a weighted average price of $75.0199, with individual sales ranging from $75.01 to $75.02.
  • The sale was executed under a pre-arranged Rule 10b5-1 trading plan established on June 13, 2024.
  • Following these transactions, Huller's direct ownership of Class A Common Stock is 0 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The use of a 10b5-1 plan suggests no unexpected or opportunistic trading.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for executives to have pre-arranged trading plans (Rule 10b5-1) to avoid accusations of trading on inside information.

Key Dates

DateDescription
2015-04-01Date the stock options were granted.
2024-06-13Date of Rule 10b5-1 trading plan.
2024-10-16Date of transaction (exercise of options and sale of shares).
2024-10-18Date of signature on the Form 4 filing.
2025-04-01Expiration date of the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.